More Americans have received a dose of at least 1 covid vaccine that has tested positive

More Americans than the initial but optimistic milestone in the race to end the epidemic have received at least one dose of the Covid-19 vaccine.

As of Monday afternoon, 26.5 million Americans had received one or both doses of the current vaccine, according to data compiled by Bloomberg Vaccine Tracker. With the first positive patient test in the U.S. outside of Seattle a year ago, 26.3 million people in the country Has tested positive for the disease, and 443,000 people have died, according to data from Johns Hopkins University.

According to data collected by Bloomberg, U.S. Shut is administering at a faster daily rate than any other country in the world. While the rollout stumbled in its early days, the first shot in the first six weeks was almost arms.8% of Americans received one or more doses and 1.8% were fully vaccinated.

“It’s noteworthy today that, for the first time, data shows that more people were vaccinated than were reported as new diagnostic cases,” said Paula Kane, a professor of microbiology at the University of Southern California’s Cake School of Medicine Medicine. “It simply came to our notice then. I am all for that win. ”


Only a few other countries have crossed that milestone: Israel, the UK and the UAE defeated the U.S. days or weeks ago in a more-than-vaccine-than-case case.

After the holiday surge in American cases, officials at the Center for Disease Control and Prevention are calling at the top, although it is due to behavioral changes, and still not having a widespread impact from the vaccine. Jay Butler, deputy director of the Agency for Infectious Diseases, said new Covid-19 cases, hospital admissions and emergency-department visits were beginning to decline.

“While these trends are encouraging, I would like to emphasize that the numbers are still high at the national level, and they are as high as any stage of the epidemic. Until This issue, ”he said at a briefing on Friday organized by the Infectious Diseases Society of America. “If this epidemic were stock, we would be willing to sell.”

It is possible for the virus to re-emerge, especially if emerging variants catch up in South Africa and elsewhere. Studies suggest that vaccines, particularly Johnson & Johnson & Novax Inc. No new shots, it’s less powerful against stress and at least one other.